Search research articles
Contact Us
Filters
Showing results (221-230 of 280) with videos related to
Page
of 28
Sort By:
Ecancermedicalscience
|
July 3, 2023
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
Manju Sengar, Wilma M Hopman, Ghulam Rehman Mohyuddin, et al.
BMJ Open
|
February 28, 2024
What can patient-reported experience measures tell us about the variation in patients' experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in England
Melanie Morris, Adrian Cook, Joanna Dodkins, et al.
Prostate Cancer and Prostatic Diseases
|
September 8, 2021
Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England
Matthew G Parry, Jemma M Boyle, Julie Nossiter, et al.
Clinical and Translational Radiation Oncology
|
May 8, 2023
Treatment-related toxicity using prostate bed versus prostate bed and pelvic lymph node radiation therapy following radical prostatectomy: A national population-based study
Arunan Sujenthiran, Matthew G Parry, Joanna Dodkins, et al.
JAMA Oncology
|
January 28, 2021
An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries
J Connor Wells, Shubham Sharma, Joseph C Del Paggio, et al.
Cancer Epidemiology
|
November 22, 2025
A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data
Orouba Almilaji, Linda Sharples, Ajay Aggarwal, et al.
Cancer Epidemiology
|
March 21, 2026
Corrigendum to "A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data" [Cancer Epidemiol. 100 (2026) 102962]
Orouba Almilaji, Linda Sharples, Ajay Aggarwal, et al.
The Lancet. Oncology
|
March 17, 2022
Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index
Gustavo A Viani, Andre G Gouveia, Vanessa F Bratti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2022
System-Level Capacity of High-Dose Rate (HDR) Brachytherapy for Management of Cervical Cancer in an Upper-Middle Income Country: A Case Study From Brazil
Andre Guimaraes Gouveia, Gustavo Arruda Viani, Vanessa Freitas Bratti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2021
In Reply to Langley et al
Matthew G Parry, Julie Nossiter, Arunan Sujenthiran, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 280) with videos related to
Sort By:
Page
of 28
Ecancermedicalscience
|
July 3, 2023
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
Manju Sengar, Wilma M Hopman, Ghulam Rehman Mohyuddin, et al.
BMJ Open
|
February 28, 2024
What can patient-reported experience measures tell us about the variation in patients' experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in England
Melanie Morris, Adrian Cook, Joanna Dodkins, et al.
Prostate Cancer and Prostatic Diseases
|
September 8, 2021
Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England
Matthew G Parry, Jemma M Boyle, Julie Nossiter, et al.
Clinical and Translational Radiation Oncology
|
May 8, 2023
Treatment-related toxicity using prostate bed versus prostate bed and pelvic lymph node radiation therapy following radical prostatectomy: A national population-based study
Arunan Sujenthiran, Matthew G Parry, Joanna Dodkins, et al.
JAMA Oncology
|
January 28, 2021
An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries
J Connor Wells, Shubham Sharma, Joseph C Del Paggio, et al.
Cancer Epidemiology
|
November 22, 2025
A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data
Orouba Almilaji, Linda Sharples, Ajay Aggarwal, et al.
Cancer Epidemiology
|
March 21, 2026
Corrigendum to "A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data" [Cancer Epidemiol. 100 (2026) 102962]
Orouba Almilaji, Linda Sharples, Ajay Aggarwal, et al.
The Lancet. Oncology
|
March 17, 2022
Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index
Gustavo A Viani, Andre G Gouveia, Vanessa F Bratti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2022
System-Level Capacity of High-Dose Rate (HDR) Brachytherapy for Management of Cervical Cancer in an Upper-Middle Income Country: A Case Study From Brazil
Andre Guimaraes Gouveia, Gustavo Arruda Viani, Vanessa Freitas Bratti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2021
In Reply to Langley et al
Matthew G Parry, Julie Nossiter, Arunan Sujenthiran, et al.
Page
of 28